Importance of Metal–Ligand Bond Stretching Frequency in Cancer Drug Activity of Ru and Os Metal Clusters    

• Authors
• Authors and affiliations

ABSTRACT

Tri-ruthenium (0) carbonyl cluster derivatives have demonstrated significant anticancer and anti-angiogenic activities, making them promising candidates for novel chemotherapy agents. These clusters exhibit moderate water solubility and stability in aqueous environments, preventing hydrolysis and decomposition within biologically relevant timeframes. This stability sets them apart from conventional ruthenium (II) and ruthenium (III) complexes, indicating their potential for enhanced therapeutic efficacy. In this study, we investigate the molecular-level interactions of tri-ruthenium carbonyl clusters functionalized with glucose-modified bicyclophosphite ligands to elucidate key factors contributing to their anticancer properties. Our findings reveal that metal-ligand bond stretching frequency, particularly CO bond vibrational characteristics, plays a crucial role in modulating the drug-like properties of these complexes. Through computational and in-silico analyses, we evaluate the corresponding osmium analogs to determine their comparative efficacy. The results highlight that osmium-based derivatives exhibit significantly higher anticancer potency, attributed to differences in metal-ligand electronic interactions. This study employs a property-based drug design (PBDD) framework, utilizing quantum mechanical approaches to predict IC50 values, LogP, and other key pharmacological parameters. By leveraging theoretical modeling and computational chemistry techniques, we provide insights into how molecular properties influence drug efficacy. Our results suggest that a systematic approach to designing transition metal-based drugs, particularly through rational ligand modifications, can enhance anticancer activity. This research opens avenues for the development of next-generation metal cluster-based chemotherapeutics with improved stability, specificity, and therapeutic performance.

Significance of the Study:

This study highlights the crucial role of metal-ligand bond stretching frequency in the anticancer efficacy of Ru and Os metal clusters. By employing computational modeling and quantum mechanical calculations, it demonstrates that osmium-based derivatives exhibit superior potency due to stronger metal-ligand interactions. The findings provide a predictive framework for designing transition metal-based chemotherapeutics with enhanced stability and specificity. This research bridges computational chemistry and pharmaceutical applications, paving the way for next-generation metal cluster-based cancer treatments.

Summary of the Study:

This study investigates the anticancer potential of tri-ruthenium (0) carbonyl clusters and their osmium analogs, focusing on metal-ligand bond stretching frequency and CO bond vibrational characteristics. Computational and in-silico analyses reveal that osmium derivatives exhibit enhanced drug activity due to optimized electronic interactions. By applying a property-based drug design (PBDD) framework, the study predicts key pharmacological parameters, offering insights into the rational design of transition metal-based chemotherapeutics for improved efficacy and stability in cancer treatment.